These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21293921)

  • 21. Survival of premenopausal breast carcinoma patients in relation to menstrual cycle timing of surgery and estrogen receptor/progesterone receptor status of the primary tumor.
    Cooper LS; Gillett CE; Patel NK; Barnes DM; Fentiman IS
    Cancer; 1999 Nov; 86(10):2053-8. PubMed ID: 10570431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adjuvant Surgical Oophorectomy Plus Tamoxifen in Premenopausal Women With Operable Hormone Receptor-Positive Breast Cancer: A Global Treatment Option.
    Love RR
    Clin Breast Cancer; 2016 Aug; 16(4):233-7. PubMed ID: 27117241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation of menstrual cycle at time of breast cancer surgery to disease-free and overall survival.
    Vanek VW; Kadivar TF; Bourguet CC
    South Med J; 1997 Aug; 90(8):780-8. PubMed ID: 9258303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmastectomy radiotherapy in premenopausal Vietnamese and Chinese women with breast cancer treated in an adjuvant hormonal therapy study.
    Love RR; Ba Duc N; Cong Binh N; Mahler PA; Thomadsen BR; Hong Long N; Shen TZ; Havighurst TC
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):697-703. PubMed ID: 12788175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Re: Mastectomy and oophorectomy by menstrual cycle phase in women with operable breast cancer.
    Ferretti G; Di Cosimo S; Carlini P; Papaldo P; Fabi A; Cognetti F
    J Natl Cancer Inst; 2002 Nov; 94(22):1720; author reply 1721-2. PubMed ID: 12441330
    [No Abstract]   [Full Text] [Related]  

  • 26. Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials.
    Regan MM; Pagani O; Francis PA; Fleming GF; Walley BA; Kammler R; Dell'Orto P; Russo L; Szőke J; Doimi F; Villani L; Pizzolitto S; Öhlschlegel C; Sessa F; Peg Cámara V; Rodríguez Peralto JL; MacGrogan G; Colleoni M; Goldhirsch A; Price KN; Coates AS; Gelber RD; Viale G;
    Breast Cancer Res Treat; 2015 Nov; 154(2):275-86. PubMed ID: 26493064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mammographic breast density, dense area, and breast area differences by phase in the menstrual cycle.
    Buist DS; Aiello EJ; Miglioretti DL; White E
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2303-6. PubMed ID: 17119062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant CMFVP versus adjuvant CMFVP plus ovariectomy for premenopausal, node-positive, and estrogen receptor-positive breast cancer patients: a Southwest Oncology Group study.
    Rivkin SE; Green S; O'Sullivan J; Cruz AB; Abeloff MD; Jewell WR; Costanzi JJ; Farrar WB; Osborne CK
    J Clin Oncol; 1996 Jan; 14(1):46-51. PubMed ID: 8558219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing estrogen and progesterone receptor patterns in breast carcinoma during the menstrual cycle and menopause.
    Pujol P; Daures JP; Thezenas S; Guilleux F; Rouanet P; Grenier J
    Cancer; 1998 Aug; 83(4):698-705. PubMed ID: 9708933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of menstrual cycle phase on surgical treatment of primary breast cancer: have we made any progress over the past 13 years?
    Hortobagyi GN
    J Natl Cancer Inst; 2002 May; 94(9):641-3. PubMed ID: 11983746
    [No Abstract]   [Full Text] [Related]  

  • 31. Ovarian Suppression With Triptorelin During Adjuvant Breast Cancer Chemotherapy and Long-term Ovarian Function, Pregnancies, and Disease-Free Survival: A Randomized Clinical Trial.
    Lambertini M; Boni L; Michelotti A; Gamucci T; Scotto T; Gori S; Giordano M; Garrone O; Levaggi A; Poggio F; Giraudi S; Bighin C; Vecchio C; Sertoli MR; Pronzato P; Del Mastro L;
    JAMA; 2015 Dec 22-29; 314(24):2632-40. PubMed ID: 26720025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Young age as an adverse prognostic factor in premenopausal women with operable breast cancer.
    Love RR; Duc NB; Dinh NV; Quy TT; Xin Y; Havighurst TC
    Clin Breast Cancer; 2002 Jan; 2(4):294-8. PubMed ID: 11899361
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Timing of surgery influences survival in receptor-negative as well as receptor-positive breast cancer.
    Saad Z; Vincent M; Bramwell V; Stitt L; Duff J; Girotti M; Jory T; Heathcote G; Turnbull I; Garcia B
    Eur J Cancer; 1994; 30A(9):1348-52. PubMed ID: 7999424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. alpha-Tocopherol concentrations in plasma but not in lipoproteins fluctuate during the menstrual cycle in healthy premenopausal women.
    Lanza E; Forman MR; Johnson EJ; Muesing RA; Graubard BI; Beecher GR
    J Nutr; 1998 Jul; 128(7):1150-5. PubMed ID: 9649599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of adjuvant tamoxifen over three decades on breast cancer-free and distant recurrence-free interval among premenopausal women with oestrogen receptor-positive breast cancer randomised in the Swedish SBII:2pre trial.
    Ekholm M; Bendahl PO; Fernö M; Nordenskjöld B; Stål O; Rydén L;
    Eur J Cancer; 2019 Mar; 110():53-61. PubMed ID: 30769227
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Menstrual timing of treatment for breast cancer.
    Senie RT; Kinne DW
    J Natl Cancer Inst Monogr; 1994; (16):85-90. PubMed ID: 7999475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women.
    Sharma R; Hamilton A; Beith J
    Cochrane Database Syst Rev; 2008 Oct; (4):CD004562. PubMed ID: 18843661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Breast cancer survival and the timing of tumor removal during the menstrual cycle.
    Chang S; Hulka BS; Baird DD; Ingle JN; Newman B; Graham ML; Qaqish B; Donohue JH; Melton LJ
    Cancer Epidemiol Biomarkers Prev; 1997 Nov; 6(11):881-6. PubMed ID: 9367060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lack of the relationship between menstrual status and timing of surgery in survival of premenopausal patients with breast cancer.
    Tsuchiya A; Furukawa H; Kanno M; Kimijima I; Abe R
    Fukushima J Med Sci; 1996 Dec; 42(1-2):11-6. PubMed ID: 9127965
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations of Serum Levels of Sex Hormones in Follicular and Luteal Phases of the Menstrual Cycle with Breast Tissue Characteristics in Young Women.
    Linton L; Taylor M; Dunn S; Martin L; Chavez S; Stanitz G; Huszti E; Minkin S; Boyd N
    PLoS One; 2016; 11(10):e0163865. PubMed ID: 27716810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.